Antigen-Antibody Reactions

Basics

Ag-Ab reaction: specific, reversible, non-covalent (H-bonds, electrostatic, van der Waals, hydrophobic) binding, Fab-epitope.

Affinity: single site binding strength. Avidity: WHOLE multivalent molecule binding strength. Avidity > sum of individual affinities (multiple bonds harder to break together). IgM: lower affinity/site but pentamer (10 sites) → high avidity → good agglutinator/complement activator.

Precipitation (SOLUBLE antigen)

Lattice formation → visible precipitate. Needs OPTIMAL proportion. Zone of equivalence = max lattice/precipitation. Prozone = antibody excess → false weak/negative. Postzone = antigen excess → false weak/negative. (Important pitfall: unexpected negative result despite strong clinical suspicion.)

Formats:

Ring test — antigen layered over antiserum, ring at interface. E.g. Ascoli’s thermoprecipitin test (anthrax).
Gel diffusion — Single (Oudin, 1 reactant diffuses) / Double (Ouchterlony, both diffuse, compare identity/partial identity/non-identity patterns)
Radial immunodiffusion (Mancini) — antigen diffuses radially into Ab-gel, ring diameter ∝ antigen concentration = QUANTITATIVE
Immunoelectrophoresis — electrophoresis + gel diffusion, resolves complex mixtures (e.g. serum proteins) into arcs

Agglutination (PARTICULATE antigen)

More SENSITIVE than precipitation (fewer Ab molecules needed to clump large particles).

Slide agglutination — rapid, qualitative (bacterial serotyping, blood grouping)
Tube agglutination — quantitative, serial dilution → titer. Widal test (typhoid), STAT (brucellosis)
Passive/indirect agglutination — soluble antigen adsorbed onto carrier (latex/RBC) → converts precipitation-type to agglutination-sensitivity
Reverse passive agglutination — antibody coated on carrier → detects ANTIGEN in specimen
Hemagglutination — Ag-coated RBC agglutinate. HAI (hemagglutination inhibition) — virus (e.g. influenza) naturally agglutinates RBC; patient Ab blocks this → FAILURE of agglutination = positive. Used for viral ID + Ab titration.
Coombs test — detects weak/hindered Ab via anti-human-globulin bridging.
- Direct Coombs — Ab already bound to patient’s own RBC in vivo (HDN, AIHA)
- Indirect Coombs — free serum Ab, incubate with test RBC first then add Coombs reagent (Rh typing, antenatal screening, cross-match)

Complement Fixation Test (CFT)

2-stage: Stage 1 — patient serum + known antigen + fixed complement → if Ab matches Ag, complement FIXED (consumed). Stage 2 — add sheep RBC + anti-sheep-RBC Ab (indicator system) → if complement already fixed = NO lysis (POSITIVE). If complement free = LYSIS (NEGATIVE).

Technically demanding (fresh complement titration needed). Mostly replaced by ELISA, still used for specific diagnoses.

Neutralization Tests

Detects loss of biological activity in presence of test serum.

ASO titer — serum blocks streptolysin O hemolysis
Viral neutralization — serum prevents CPE in cell culture

Immunofluorescence

Fluorescent dye (usually FITC) conjugated to Ab, visualized under fluorescence microscope.

Direct IF (DIF): labelled Ab detects ANTIGEN directly (rabies Ag in skin/brain biopsy, tissue-bound Ig in Goodpasture kidney biopsy). Indirect IF (IIF): detects patient ANTIBODY. Unlabelled patient serum + known antigen substrate → labelled anti-human-globulin visualizes bound Ab. Used: ANA (SLE), other autoimmune/infectious Ab profiles.

ELISA

Modern standard. Enzyme-Ab conjugate + substrate → color change (spectrophotometric). Objective, quantifiable, automatable.

Direct ELISA — labelled Ab detects antigen directly
Indirect ELISA — antigen fixed to plate + patient serum + enzyme-labelled anti-human-globulin = detects patient Ab
Sandwich ELISA — capture Ab (plate) + antigen (specimen) + labelled detection Ab (different epitope) = detects ANTIGEN. Basis of most rapid antigen tests (HBsAg, dengue NS1).
Competitive ELISA — labelled vs unlabelled reagent compete for limited binding sites. Useful for small/single-epitope molecules.

RIA (Radioimmunoassay)

Radioactive label, bound/free separated, radioactivity measured. Very sensitive, OLDER, mostly replaced by ELISA (avoids radioactive waste handling).

Western Blot

Proteins separated by size (gel) → blotted to membrane → probed with labelled Ab → detects specific protein in complex mixture. Used as CONFIRMATORY test (e.g. confirmatory HIV testing, cysticercosis specific antigen bands).

The Basis of Serological Testing

An antigen-antibody reaction is the specific, reversible, non-covalent binding of an antibody’s Fab region to its matching epitope — held together by hydrogen bonds, electrostatic forces, van der Waals forces, and hydrophobic interactions rather than any covalent bond. This specificity and reversibility is exactly what makes the reaction usable diagnostically: whether an antibody in a patient’s serum recognizes a known antigen (or vice versa) can be read out as a visible, measurable endpoint, and that endpoint is what the entire discipline of serology is built on.

Affinity describes the binding strength of a single antibody-combining site for its epitope; avidity describes the overall binding strength of a whole multivalent antibody molecule (or antibody population) for a multivalent antigen — avidity is always greater than the sum of individual affinities, because multiple simultaneous bonds are harder to break all at once than any one bond alone. This is exactly why IgM, despite having lower affinity per site than IgG, is such an effective agglutinator and complement activator: its pentameric structure gives it ten binding sites, and the resulting avidity more than compensates.

Types of Antigen-Antibody Reactions

Precipitation

When a soluble antigen reacts with its antibody in optimal proportions, the resulting antigen-antibody complexes cross-link into a lattice large enough to fall out of solution as a visible precipitate. The zone of equivalence — where antigen and antibody concentrations are balanced enough to form this maximal lattice — is what actually produces visible precipitation; antigen or antibody excess on either side of this zone (the prozone phenomenon, antibody excess, and postzone, antigen excess) prevents lattice formation and gives a falsely weak or negative result, a genuinely important pitfall when interpreting a serological test that comes back unexpectedly negative in a patient with strong clinical suspicion.

Precipitation reactions are run in two main formats: ring test (layering antigen over antiserum in a tube, reading a precipitate ring at the interface — the classic ascoli’s thermoprecipitin test for anthrax) and gel diffusion, where antigen and antibody diffuse toward each other through a gel matrix — single diffusion (Oudin technique), where only one reactant diffuses, and double diffusion (Ouchterlony technique), where both diffuse from separate wells and meet to form a precipitin line, useful for comparing antigens (identity, partial identity, or non-identity patterns between adjacent wells). Radial immunodiffusion (Mancini technique) — antigen diffusing radially into antibody-containing gel, with the diameter of the resulting precipitin ring proportional to antigen concentration — allows quantification. Immunoelectrophoresis combines electrophoretic separation with gel diffusion to resolve complex antigen mixtures (e.g. serum proteins) into individual precipitin arcs.

Agglutination

When a particulate antigen (whole bacteria, red cells, or antigen artificially coated onto latex/other carrier particles) reacts with antibody, cross-linking causes visible clumping — agglutination is a more sensitive reaction than precipitation, since fewer antibody molecules are needed to visibly clump large particles than to precipitate small soluble molecules.

Slide agglutination — rapid, qualitative, antigen and serum mixed directly on a slide (bacterial serotyping, blood grouping).
Tube agglutination — quantitative, serial serum dilutions against a fixed antigen amount, read for the highest dilution (titre) still showing agglutination — the Widal test for typhoid and the standard tube agglutination test (STAT) for brucellosis both use this format.
Passive (indirect) agglutination — soluble antigen is artificially adsorbed onto an inert carrier (latex beads, red cells) to convert a precipitation-type reaction into the more sensitive agglutination format; reverse passive agglutination does the same with antibody coated onto the carrier, to detect antigen in a specimen instead.
Hemagglutination — antigen-coated (or naturally antigen-bearing) red cells agglutinate specifically; hemagglutination inhibition (HAI) exploits this in reverse — a virus that naturally agglutinates red cells (e.g. influenza) is mixed with patient serum first, and if the serum contains specific antibody, it blocks the virus’s hemagglutinating activity, seen as failure of agglutination — used both to identify a virus and to titrate antiviral antibody.
Coombs test — detects antibody too weak or too sterically hindered to directly agglutinate antibody-coated red cells on its own; anti-human-globulin (Coombs reagent) is added to bridge and agglutinate the antibody-coated cells. Direct Coombs detects antibody already bound to a patient’s own red cells in vivo (haemolytic disease of the newborn, autoimmune haemolytic anaemia); indirect Coombs detects free antibody in serum by first incubating it with test red cells, then adding Coombs reagent (Rh typing, antenatal antibody screening, cross-matching before transfusion).

Complement Fixation Test (CFT)

A two-stage test exploiting the fact that complement, once “fixed” (consumed) by an antigen-antibody complex in stage one, is no longer available to lyse an indicator system added in stage two. Patient serum, known antigen, and a fixed amount of complement are incubated first; if the patient’s antibody matches the antigen, complement is fixed (consumed) by the resulting complex. Sheep RBCs pre-coated with anti-sheep-RBC antibody are then added: if complement was already fixed in stage one, none remains to lyse these indicator cells (a positive result — no haemolysis); if the patient lacked matching antibody, complement remains free and lyses the indicator cells (a negative result — visible haemolysis). CFT is technically demanding (complement must be freshly titrated and standardized) and has been substantially replaced by ELISA-based methods, though it remains historically important and is still used for a handful of specific serological diagnoses.

Neutralization Tests

Antibody that specifically neutralizes a toxin or virus’s biological activity is detected by demonstrating the loss of that activity in the presence of test serum — the antistreptolysin O (ASO) titre (patient serum’s ability to block streptolysin O’s haemolytic activity) and viral neutralization tests (patient serum’s ability to prevent a virus from producing cytopathic effect in cell culture) are the classic examples.

Immunofluorescence

A fluorescent dye (commonly FITC) is conjugated to an antibody, and the antigen-antibody complex is visualized directly under a fluorescence microscope. Direct immunofluorescence (DIF) uses a fluorescent-labelled antibody to detect antigen directly in a specimen (e.g. rabies antigen in a skin/brain biopsy, or tissue-bound immunoglobulin in a Goodpasture-syndrome kidney biopsy). Indirect immunofluorescence (IIF) detects patient antibody instead: unlabelled patient serum is first incubated with a known antigen substrate, then a fluorescent-labelled anti-human-globulin is added to visualize any antibody that bound — the format used for ANA testing in SLE and for confirming several other autoimmune and infectious antibody profiles.

Enzyme-Linked Immunosorbent Assay (ELISA)

The dominant modern serological format, using an enzyme-antibody conjugate (rather than a fluorescent tag) whose enzymatic reaction with a substrate produces a colour change read spectrophotometrically — objective, quantifiable, and automatable, which is exactly why it has displaced CFT and many older formats for routine use. Direct ELISA detects antigen with a labelled antibody directly. Indirect ELISA detects patient antibody: antigen is fixed to a plate, patient serum is added, then an enzyme-labelled anti-human-globulin detects any bound patient antibody. Sandwich ELISA detects antigen between two antibodies — a capture antibody fixed to the plate binds antigen from the specimen, then a second, enzyme-labelled detection antibody binds a different epitope on the same antigen, “sandwiching” it — this format is what most rapid antigen tests (HBsAg, dengue NS1, and similar) are built on. Competitive ELISA detects antigen or antibody by competition between labelled and unlabelled reagent for a limited number of binding sites, useful for small molecules with only one epitope, where a sandwich format isn’t possible.

Radioimmunoassay (RIA)

An older but extremely sensitive format using a radioactively-labelled antigen or antibody, with bound and free fractions separated and the radioactivity measured — largely displaced by ELISA in routine practice because it avoids radioactive waste-handling requirements, though RIA’s sensitivity is still occasionally unmatched for specific research applications.

Western Blot

Proteins are separated by size on a gel, transferred (blotted) onto a membrane, and probed with labelled antibody to detect a specific protein among a complex mixture — used as a confirmatory test where a screening ELISA needs independent verification (e.g. confirmatory HIV testing, and detecting specific antigen bands in cysticercosis serology).